Selected article for: "future study and host response"

Author: C Langelier; MS Zinter; K Kalantar; GA Yanik; S Christenson; B Odonovan; C White; M Wilson; A Sapru; CC Dvorak; S Miller; CY Chiu; JL DeRisi
Title: Metagenomic Sequencing Detects Respiratory Pathogens in Hematopoietic Cellular Transplant Patients
  • Document date: 2017_1_24
  • ID: km0b1z64_57
    Snippet: The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. . https://doi.org/10.1101/102798 doi: bioRxiv preprint Page 18 of 29 host response and the airway microbiome. We suggest several ways in which future studies may improve on this proof-of-concept study, including validation in a larger prospective cohort of HCT recipients and other high-risk populations......
    Document: The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. . https://doi.org/10.1101/102798 doi: bioRxiv preprint Page 18 of 29 host response and the airway microbiome. We suggest several ways in which future studies may improve on this proof-of-concept study, including validation in a larger prospective cohort of HCT recipients and other high-risk populations.

    Search related documents:
    Co phrase search for related documents
    • airway microbiome and concept proof study: 1
    • airway microbiome and high risk: 1, 2, 3
    • airway microbiome and host response: 1, 2, 3, 4
    • airway microbiome and prospective cohort: 1, 2
    • concept proof and future study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • concept proof and high risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • concept proof and host response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • concept proof and prospective cohort: 1, 2
    • concept proof study and future study: 1, 2, 3, 4, 5, 6
    • concept proof study and high risk: 1, 2, 3, 4, 5
    • concept proof study and host response: 1, 2, 3, 4
    • concept proof study and prospective cohort: 1
    • future study and high risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • future study and high risk population: 1, 2
    • future study and host response: 1, 2, 3, 4
    • future study and prospective cohort: 1, 2, 3, 4, 5
    • HCT recipient and high risk: 1
    • HCT recipient and prospective cohort: 1
    • high risk and prospective cohort: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25